PMID: 9631930Jun 19, 1998Paper

Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A

Therapeutic Drug Monitoring
J A CarrilloJ Benitez

Abstract

Hydroxylation of midazolam (MDZ) is mediated almost exclusively by CYP3A isoforms. The authors describe a high-performance liquid chromatography assay involving MDZ, 1'-hydroxymidazolam, and 4-hydroxymidazolam in plasma. The compounds were eluted on an Ultrasphere ODS, 3-microm particle size, 7.5 cm x 4.6 mm reversed-phase column and monitored by ultraviolet absorbance at 254 nm. The composition of the mobile phase was 35.2% acetonitrile:4.8% methanol:60% buffer acetate (vol/vol/vol), 0.1 M, pH 4.7; the flow rate was 1 ml/minute. Calibration curves were linear (coefficients of correlation > 0.99) within the range of concentrations established (20 to 640 nM). Within- and between-day coefficients of variation were consistently better than 8%. The overall recovery was >90% and the lowest detectable concentration was 8 nM. This approach provides a simple, rapid, and sensitive assessment of MDZ and metabolites in plasma, with a very good accuracy and precision, which enables it as an in vivo marker of CYP3A activity in humans.

References

Aug 1, 1995·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·N A von Rosensteil, D Adam
Sep 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P B Watkins
Jan 1, 1995·Clinical Pharmacology and Therapeutics·K S LownP B Watkins
Aug 1, 1994·Pharmacogenetics·P B Watkins
Dec 1, 1994·Clinical Pharmacology and Therapeutics·P BurtinP Mussat
May 1, 1994·Clinical Pharmacology and Therapeutics·K T OlkkolaP J Neuvonen
Mar 1, 1993·Clinical Pharmacology and Therapeutics·K T OlkkolaP J Neuvonen
Jan 1, 1996·Clinical Pharmacology and Therapeutics·J T BackmanP J Neuvonen
May 1, 1996·Clinical Pharmacology and Therapeutics·K E ThummelG R Wilkinson
Jul 1, 1996·Clinical Pharmacology and Therapeutics·M F PaineK E Thummel
Dec 1, 1995·Journal of Clinical Psychopharmacology·T A KetterA M Callahan
Jan 1, 1997·Clinical Pharmacology and Therapeutics·K VillikkaP J Neuvonen

❮ Previous
Next ❯

Citations

Jul 13, 2006·European Journal of Clinical Pharmacology·Emmanuel KrupkaMarie-Christine Perault
Jul 11, 2012·European Journal of Clinical Pharmacology·Sara K QuinneyStephen D Hall
Mar 1, 2003·Drug and Alcohol Dependence·Marc ShindermanChin B Eap
Oct 1, 2008·The Pharmacogenomics Journal·M A PereraA Di Rienzo
Jun 10, 2009·The Pharmacogenomics Journal·J MiaoS D Hall
Oct 6, 2007·Biological & Pharmaceutical Bulletin·Fusako NagaiHiroomi Tamura
Sep 8, 2000·Clinical Pharmacokinetics·J A Carrillo, J Benitez
Jun 26, 2004·Clinical Pharmacokinetics·Ichiro IeiriKenji Otsubo
Mar 15, 2005·Clinical Pharmacokinetics·Shufeng ZhouHoward L McLeod
Jul 1, 2009·Bioanalysis·Victoria F SamanidouIoannis N Papadoyannis
Dec 3, 2014·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·R Sánchez-CarpinteroM A Cebollero
Mar 28, 2003·Journal of Pharmaceutical Sciences·Toyohiro SawadaMasahiro Hayashi
Jul 20, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Xin WangJohn H K Yeung
Jun 12, 2010·Journal of Pharmaceutical and Biomedical Analysis·Dalia A Hamdy, Dion R Brocks
Mar 13, 2003·British Journal of Clinical Pharmacology·Bing ZhuHong-Hao Zhou
Feb 24, 2007·Pharmacotherapy·Sean P Spina, Mary H H Ensom
Dec 17, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Toshiyuki IwasakiMakiko Osawa
Mar 23, 2011·Phytotherapy Research : PTR·Xin Wang, John H K Yeung
Jul 5, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Valquiria A P JaborVera L Lanchote
Nov 13, 2004·Rapid Communications in Mass Spectrometry : RCM·Oscar QuintelaManuel López-Rivadulla
Jul 16, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Takushi KanazuMasahiro Koike
Jun 8, 2007·Biochimica Et Biophysica Acta·Auryan SzalatVardiella Meiner
Dec 18, 2001·Rapid Communications in Mass Spectrometry : RCM·G FrisonS D Ferrara
May 26, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Simon N MuchohiGilbert O Kokwaro
Mar 20, 2004·Journal of Pharmaceutical and Biomedical Analysis·S R HarrisM Savage
Nov 7, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mikiko ShimizuTomonori Tateishi
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·Zhao-Qian LiuHong-Hao Zhou
Oct 8, 2017·European Journal of Clinical Pharmacology·Xuan ZhouYong Lai
Dec 18, 2001·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Masanori KurohaEiichi Kokue
Dec 7, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Weiyao DingYong Lai
Feb 5, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Rui HeJinguang Ruan
Jan 19, 2021·Biomedical Chromatography : BMC·Sara Batista do NascimentoWhocely Victor de Castro
Jan 30, 2002·Journal of Pharmaceutical and Biomedical Analysis·M M Hefnawy
Oct 30, 2021·Clinical Pharmacology in Drug Development·Dirk KropeitHelga Rübsamen-Schaeff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.